RecruitingNot ApplicableNCT06704958

Augmented Momentary Personal Ecological Risk Evaluation


Sponsor

University of Washington

Enrollment

50 participants

Start Date

Sep 25, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this intervention study is to co-design and test an Ecological Momentary Assessment (EMA) prototype tool with young adults aged 16-30 experiencing suicidality to see if it is an acceptable and usable clinical tool for risk management. The main study aims are: * To co-design a prototype EMA suicide risk monitoring system with patients and health care provider input using Human Centered Design (HCD) methods. * To test the developed EMA protype with providers and their young adult patients aged 16-30 experiencing suicidality to determine if the EMA prototype is an acceptable and usable clinical tool. Young adult participants receiving care for active suicidal ideation will * Download and use the EMA prototype for a total of two months. * Complete 3 online surveys at 0, 1 and 2 months after enrolled in the study.


Eligibility

Min Age: 16 YearsMax Age: 30 Years

Inclusion Criteria3

  • Young adults (age 16-30 years)
  • Receiving care at University of Washington Primary Care for suicidal ideation as determined by Electronic Health Record problem list or PHQ-9 suicide risk item >0 in previous year and/or recent (past year) history of suicide attempt and/or active suicidal ideation.
  • Ability to consent to participate

Exclusion Criteria4

  • Age <16 or >30,
  • Non-English speaking
  • No smart phone access
  • Any clinical medical/psychiatric condition, severity of that condition, or life situation that would compromise safe and voluntary study participation.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAMPERE EMA app

AMPERE EMA smartphone app using MyCap


Locations(1)

University of Washington

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06704958


Related Trials